0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

JAMA Patient Page |  FREE
Ibrahim Nassour, MD; Michael A. Choti, MD, MBA
JAMA. 2016;316(11):1226. doi:10.1001/jama.2016.9035.

JAMA Patient Page |  FREE
Amy E. Thompson, MD
JAMA. 2016;316(10):1124. doi:10.1001/jama.2016.3592.

A Piece of My Mind | 
Gilad D. Evrony, MD, PhD
JAMA. 2016;316(7):713-714. doi:10.1001/jama.2016.4994.

News From the Food and Drug Administration | 
Rebecca Voelker, MSJ
JAMA. 2016;316(5):485. doi:10.1001/jama.2016.9769.

JAMA Diagnostic Test Interpretation | 
Lydia Usha, MD; Summer B. Dewdney, MD; Lela E. Buckingham, PhD
JAMA. 2016;316(1):93-94. doi:10.1001/jama.2016.8286.

Editorial | 
Boris Pasche, MD, PhD; Michael J. Pennison, PhD; Barry DeYoung, MD
JAMA. 2016;316(1):38-39. doi:10.1001/jama.2016.8291.

Clinical Trials Update | 
Anita Slomski, MA
JAMA. 2016;315(24):2656. doi:10.1001/jama.2016.7253.

Review | 
Herbert L. DuPont, MD
JAMA. 2016;315(24):2712-2723. doi:10.1001/jama.2016.7833.
Includes: CME

Medical News & Perspectives | 
Julie A. Jacob, MA
JAMA. 2016;315(24):2653-2654. doi:10.1001/jama.2016.6295.

US Preventive Services Task Force |  FREE
US Preventive Services Task Force
JAMA. 2016;315(23):2564-2575. doi:10.1001/jama.2016.5989.
Includes: CME

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Editorial  | 
Surveillance of Hepatocellular Carcinoma by Magnetic Resonance Imaging With Liver-Specific Contrast
Tung-Hung Su, MD, PhD; Jia-Horng Kao, MD, PhD
JAMA Oncology
Original Investigation  | 
MRI With Liver-Specific Contrast for Surveillance of Patients With Cirrhosis at High Risk of Hepatocellular Carcinoma
So Yeon Kim, MD, PhD; Jihyun An, MD; Young-Suk Lim, MD, PhD; et al.
JAMA Oncology
Original Investigation  | 
Ramucirumab as Second-Line Treatment in Patients With Advanced Hepatocellular Carcinoma Analysis of REACH Trial Results by Child-Pugh Score
Andrew X. Zhu, MD, PhD; Ari David Baron, MD; Peter Malfertheiner, MD; et al.
JAMA Surgery
Research Letter  | 
Comparative Effectiveness of Preoperative Treatment Regimens in Patients With Potentially Resectable Esophageal Cancer
Jennifer M. Duff, MD; H. Charles Peters, MD; William Zingarelli, MD; et al.